Related Experiment Video

Updated: May 28, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability

Liang-Chuan S Wang1, Rachel C Lynn, Guanjun Cheng

  • 1Division of Pulmonary, Thoracic Oncology Research Laboratory, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|October 20, 2011
PubMed

Insights

A novel vaccinia virus expressing mouse interferon-beta (VV.mIFNβ) showed antitumor effects in lung cancer models. Mechanisms varied, involving immune activation or direct oncolysis, highlighting virus-immune interactions for immunotherapy enhancement.

Area of Science:

  • Oncolytic virotherapy
  • Immunotherapy
  • Cancer research

Background:

  • Previous studies utilized nonreplicating adenovirus expressing mouse interferon-beta (Ad.mIFNβ) with promising preclinical activity.
  • A replication-competent vector expressing interferon-beta at high levels was hypothesized to be more beneficial.

Purpose of the Study:

  • To evaluate a recombinant vaccinia viral vector expressing mouse interferon-beta (VV.mIFNβ) for its antitumor efficacy.
  • To investigate the distinct mechanisms of tumor killing induced by VV.mIFNβ in different murine lung cancer models.

Main Methods:

  • Development and testing of a replication-competent vaccinia viral vector expressing mouse interferon-beta (VV.mIFNβ).
  • Assessment of in vivo antitumor responses in two syngeneic mouse flank models of lung cancer (LKRM2 and TC-1).
  • Analysis of viral replication, immune response induction (innate and adaptive, including CD8 T-cells), and direct oncolytic effects.

Main Results:

  • VV.mIFNβ demonstrated antitumor activity in both LKRM2 and TC-1 lung cancer models with equivalent efficacy.
  • In LKRM2 tumors, minimal viral replication occurred, with tumor killing driven by immune activation and CD8 T-cell production.
  • In TC-1 tumors, significant viral replication led to direct oncolysis, with VV.mIFNβ also augmenting antitumor vaccine efficacy by increasing CD8 T-cell infiltration.

Conclusions:

  • VV.mIFNβ exhibits potent antitumor activity through distinct mechanisms dependent on the tumor microenvironment.
  • The study underscores the complex interplay between oncolytic viruses and the immune system.
  • Understanding these interactions is crucial for harnessing oncolytic viruses to enhance cancer immunotherapy efficacy.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...